Staley A. Brod

1.9k total citations
70 papers, 1.6k citations indexed

About

Staley A. Brod is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Staley A. Brod has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 26 papers in Pathology and Forensic Medicine and 19 papers in Oncology. Recurrent topics in Staley A. Brod's work include Multiple Sclerosis Research Studies (25 papers), T-cell and B-cell Immunology (20 papers) and Immune Cell Function and Interaction (18 papers). Staley A. Brod is often cited by papers focused on Multiple Sclerosis Research Studies (25 papers), T-cell and B-cell Immunology (20 papers) and Immune Cell Function and Interaction (18 papers). Staley A. Brod collaborates with scholars based in United States, India and Canada. Staley A. Brod's co-authors include Jerry S. Wolinsky, David A. Hafler, John Lindsey, Dennis K. Burns, Evelyn Henninger, Laura D. Nelson, Howard L. Weiner, Gailen D. Marshall, Flavia Nelson and David Benjamin and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Neurology.

In The Last Decade

Staley A. Brod

70 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Staley A. Brod United States 23 872 411 304 222 214 70 1.6k
Hirofumi Ochi Japan 24 649 0.7× 654 1.6× 194 0.6× 468 2.1× 137 0.6× 89 1.8k
Takayuki Kondo Japan 19 1.7k 1.9× 533 1.3× 277 0.9× 198 0.9× 136 0.6× 41 2.4k
Jeri‐Anne Lyons United States 19 1.0k 1.2× 925 2.3× 331 1.1× 305 1.4× 147 0.7× 46 2.0k
Charlotte Dahle Sweden 21 596 0.7× 900 2.2× 231 0.8× 400 1.8× 96 0.4× 69 1.8k
Ian Sutton Australia 20 542 0.6× 363 0.9× 233 0.8× 814 3.7× 224 1.0× 43 2.0k
Patricia A. Nelson United States 17 676 0.8× 438 1.1× 127 0.4× 186 0.8× 77 0.4× 27 1.4k
Christopher Harp United States 18 900 1.0× 607 1.5× 184 0.6× 187 0.8× 75 0.4× 32 1.8k
Subramaniam Sriram United States 30 1.0k 1.2× 529 1.3× 404 1.3× 210 0.9× 140 0.7× 66 2.5k
Hikoaki Fukaura Japan 13 694 0.8× 489 1.2× 140 0.5× 301 1.4× 78 0.4× 34 1.2k
Anneli Peters Germany 12 1.4k 1.6× 352 0.9× 376 1.2× 81 0.4× 104 0.5× 23 2.0k

Countries citing papers authored by Staley A. Brod

Since Specialization
Citations

This map shows the geographic impact of Staley A. Brod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Staley A. Brod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Staley A. Brod more than expected).

Fields of papers citing papers by Staley A. Brod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Staley A. Brod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Staley A. Brod. The network helps show where Staley A. Brod may publish in the future.

Co-authorship network of co-authors of Staley A. Brod

This figure shows the co-authorship network connecting the top 25 collaborators of Staley A. Brod. A scholar is included among the top collaborators of Staley A. Brod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Staley A. Brod. Staley A. Brod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brod, Staley A.. (2022). The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica. Autoimmunity Reviews. 21(10). 103170–103170. 1 indexed citations
2.
Brod, Staley A.. (2020). Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects. Multiple Sclerosis and Related Disorders. 46. 102538–102538. 32 indexed citations
3.
Freedman, Mark S., Staley A. Brod, B. Singer, et al.. (2019). Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS. Journal of Neurology. 267(1). 64–75. 4 indexed citations
4.
Dittel, Bonnie N., et al.. (2019). Ingested ACTH blocks Th17 production by inhibiting GALT IL-6. Journal of the Neurological Sciences. 409. 116602–116602. 15 indexed citations
5.
Brod, Staley A.. (2016). Ingested (oral) rituximab inhibits EAE. Cytokine. 85. 177–183. 6 indexed citations
6.
Brod, Staley A., et al.. (2014). Ingested (oral) tocilizumab inhibits EAE. Cytokine. 68(2). 86–93. 12 indexed citations
7.
Brod, Staley A., et al.. (2012). Ingested (oral) neuropeptide Y inhibits EAE. Journal of Neuroimmunology. 250(1-2). 44–49. 5 indexed citations
8.
Brod, Staley A., et al.. (2008). Ingested (Oral) SIRS Peptide 1-21 Suppresses Type 1 Diabetes in NOD Mice. Journal of Interferon & Cytokine Research. 28(1). 25–30. 7 indexed citations
9.
Brod, Staley A., et al.. (2006). Ingested (Oral) IFN- α Represses TNF- α mRNA in Relapsing-Remitting Multiple Sclerosis. Journal of Interferon & Cytokine Research. 26(3). 150–155. 10 indexed citations
10.
Brod, Staley A.. (2002). Ingested Type I Interferon: A Potential Treatment for Autoimmunity. Journal of Interferon & Cytokine Research. 22(12). 1153–1166. 16 indexed citations
11.
Brod, Staley A., Mark A. Atkinson, Victor Lavis, et al.. (2001). Ingested IFN- α Preserves Residual β Cell Function in Type 1 Diabetes. Journal of Interferon & Cytokine Research. 21(12). 1021–1030. 20 indexed citations
12.
13.
Brod, Staley A.. (1997). Gut Response. Archives of Neurology. 54(10). 1300–1300. 8 indexed citations
14.
15.
Vriesendorp, Francine J., et al.. (1996). Oral Administration of Type I Interferon Modulates the Course of Experimental Allergic Neuritis. Autoimmunity. 24(3). 157–165. 18 indexed citations
16.
Brod, Staley A., John J. Bright, Subramaniam Sriram, et al.. (1995). Decreased CD3‐mediated interferon‐γ production in relapsing‐remitting multiple sclerosis. Annals of Neurology. 37(4). 546–549. 11 indexed citations
17.
18.
Weiner, Howard L., Samia J. Khoury, Ariel Miller, et al.. (1991). Antigen‐Driven Peripheral Immune Tolerance. Annals of the New York Academy of Sciences. 636(1). 227–232. 21 indexed citations
19.
Brod, Staley A., et al.. (1989). Lymphokine regulation of CD45R expression on human T cell clones.. The Journal of Experimental Medicine. 170(6). 2147–2152. 56 indexed citations
20.
Brod, Staley A., Laura R. Ment, Richard A. Ehrenkranz, & Samuel L. Bridgers. (1988). Predictors of success for drug discontinuation following neonatal seizures. Pediatric Neurology. 4(1). 13–17. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirofumi Ochi Breakdown of academic impact, for papers by Takayuki Kondo Breakdown of academic impact, for papers by Jeri‐Anne Lyons Breakdown of academic impact, for papers by Charlotte Dahle Breakdown of academic impact, for papers by Ian Sutton Breakdown of academic impact, for papers by Patricia A. Nelson Breakdown of academic impact, for papers by Christopher Harp Breakdown of academic impact, for papers by Subramaniam Sriram Breakdown of academic impact, for papers by Hikoaki Fukaura Breakdown of academic impact, for papers by Anneli Peters
Rankless by CCL
2026